Pharmabiz

Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis

Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis: Washington Tuesday, December 16, 2025, 15:00 Hrs [IST] Vanda Pharmaceuticals Inc., (Van ...
Pharmabiz

Gujarat Kidney and Super Speciality’s IPO to open on Monday, December 22, 2025

Gujarat Kidney and Super Speciality, a regional healthcare company located in Gujarat, announced that its initial public offering (IPO) for subscription from Monday, 22nd December, 2025, and closes on ...
Pharmabiz

Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor

Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor: Hong Kong Tuesday, December 16, 2025, 14:3 ...
Pharmabiz

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD: Melbourne, Australia Tuesday, December 16, 2025, 14:00 ...
Pharmabiz

DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing

DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing: Our Bureau, Bengaluru Tuesday, December 16, 2025, 13:50 Hrs [IST] Dnyaan ...
Pharmabiz

Lupin secures SBTi validation for emission reduction targets

Global pharma major Lupin Limited (Lupin) announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). These ...
Pharmabiz

IMA Kurukshetra hosts special session on drugs and cosmetics act

IMA Kurukshetra hosts special session on drugs and cosmetics act: Our Bureau, Chennai Tuesday, December 16, 2025, 13:30 Hrs [IST] The Indian Medical Association (IMA) Kurukshetra ...
Pharmabiz

Hanahealth by DSS Imagetech takes GERI time-lapse incubator pan India

Hanahealth by DSS Imagetech takes GERI time-lapse incubator pan India: Our Bureau, Mumbai Tuesday, December 16, 2025, 13:40 Hrs [IST] Reiterating its commitment to revolutionising ...
Pharmabiz

Bioretec’s RemeOs DrillPin receives US FDA Breakthrough Device Designation

Bioretec’s RemeOs DrillPin receives US FDA Breakthrough Device Designation: Finland Tuesday, December 16, 2025, 13:00 Hrs [IST] Bioretec Oy (Bioretec), a pioneer in biodegradabl ...
Pharmabiz

GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe

GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe: Athens, Greece Tuesday, December 16, ...
Pharmabiz

Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint

Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint: Paris Tuesday, December 16, 2025, 11:00 Hrs [IST] Sanofi ...
Pharmabiz

Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training

Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training: Tuesday, December 16, 2025, 08:00 Hrs [IST] Lalit Kumar Goel, State ...